Physician

Alain L. Heroux, MD

According to 2025 Medicare claims, Alain Heroux, MD (NPI: 1609945195) practices advanced heart failure and transplant cardiology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is LOYOLA UNIVERSITY MEDICAL CENTER (NPI: 1336159961; TIN: 364015560) and primary practice location at 60153-3328. Heroux is affiliated with the OSF Healthcare System (ACO ID: A3289) and Trinity Health Integrated Care (ACO ID: A3454), participating under the MSSP model.

Heroux's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 286 traditional Medicare patients, billed 1,834 HCPCS/CPT codes, and received $150,759 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 4,233 prescription claims across 313 beneficiaries totaling $713,198 in drug costs, led by Entresto (Sacubitril/Valsartan). DME data shows 1,317 claims. Open Payments data shows 3 records totaling $11,154. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $26,711 and ending at $27,252.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	413	2,880	$195,176
2016	401	3,000	$202,781
2017	381	3,572	$253,797
2018	378	2,347	$178,253
2019	379	2,367	$181,860
2020	362	2,744	$209,119
2021	358	2,934	$241,164
2022	314	2,176	$174,515
2023	291	1,844	$158,582
2024	286	1,834	$150,759

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	289	5,032	$583,570
2016	286	4,883	$579,286
2017	306	4,827	$724,022
2018	321	4,763	$696,614
2019	340	4,618	$646,509
2020	375	4,344	$805,969
2021	377	4,628	$705,828
2022	360	4,502	$703,567
2023	327	3,999	$694,886
2024	313	4,233	$713,198

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	205	2,037	$370,537
2016	179	2,270	$421,451
2017	202	1,977	$143,101
2018	250	2,677	$204,631
2019	247	2,548	$174,908
2020	186	2,103	$150,190
2021	154	2,089	$141,176
2022	150	1,773	$90,355
2023	110	1,622	$76,797
2024	88	1,317	$43,901

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	56	67	$133
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	101	230	$109
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	82	565	$97
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	201	525	$74
93750	Evaluation of lower heart chamber assist device	28	359	$34

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Entresto	Sacubitril/Valsartan	243	16,046	$344,785
Eliquis	Apixaban	48	2,890	$54,084
Jardiance	Empagliflozin	37	2,790	$53,531
Farxiga	Dapagliflozin Propanediol	26	1,620	$29,351
Tacrolimus	Tacrolimus	131	9,668	$24,351

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7503	Tacrolimus, extended release, (envarsus xr), oral, 0.25 mg	N	N/R	13	$8,589
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	51	$5,796
J7507	Tacrolimus, immediate release, oral, 1 mg	N	22	266	$4,590
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	23	313	$4,421
J7515	Cyclosporine, oral, 25 mg	N	N/R	45	$4,224

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$31	Lexicon Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$11,123	AstraZeneca Pharmaceuticals LP
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alain L. Heroux, MD?

Tedicare shows public-source Medicare data for Alain L. Heroux, MD (NPI 1609945195), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alain L. Heroux, MD have ACO affiliation data?

Alain L. Heroux, MD is shown with ACO affiliation data for OSF Healthcare System (MSSP, ACO ID A3289) and Trinity Health Integrated Care (MSSP, ACO ID A3454).

What billing organization is linked to Alain L. Heroux, MD?

Alain L. Heroux, MD is linked to LOYOLA UNIVERSITY MEDICAL CENTER (billing NPI 1336159961) in the available physician profile data.

Does Alain L. Heroux, MD have Open Payments data?

Alain L. Heroux, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.